Overview
Guardian Pharmacy was founded in 2004 and currently operates 50 pharmacies serving around 174,000 residents in 36 states. Its main competitors are Omnicare, PharMerica Corporation, Remedi SeniorCare, and PharmCareUSA. The company is led by president and chief executive officer Fred Burke.
The management plans to use $55.2 million of the net proceeds from the offering to fund the aggregate cash portion of merger consideration – before the offering, the company will merge with a transitory merger subsidiary and will survive the merger as a wholly-owned subsidiary of Guardian Inc. Around $20 million of the proceeds will be used to repay certain borrowings on the line of credit under the existing credit facility. The remainder of the fund will be used for general corporate purposes and working capital.
Financials
Guardian Pharmacy’s annual revenues increased steadily and reached $1.05 billion in the year ended December 2023, nearly doubling over the past five years. Full-year net income was $37.7 million, compared to $49.7 million for the year ended December 2022. Adjusted EBITDA increased to $76.2 million in 2023 from $65.7 million in the previous year.
The scale of the business has helped the company make major investments to ramp up its pharmacies and achieve operational efficiencies. The main areas of investment include logistics management, revenue cycle management, automated robotic dispensing technology, compliance packaging, pharmacy workflow software, and disaster recovery business continuity.